Page 34 - Essentia Vol 5 Issue 1
P. 34

VOL V | ISSUE I | 5 AUGUST 2026            VOL V | ISSUE I | 5 AUGUST 2026
              A BIANNUAL NEWSLETTER OF ASSAM CANCER CARE FOUNDATION                                                                                                                                              A BIANNUAL NEWSLETTER OF ASSAM CANCER CARE FOUNDATION

                 districts with the highest documented burden      see-and-treat protocols wherever feasible to
                 (Papumpare-pattern  districts  of  Arunachal      reduce  loss  to  follow-up  between  screening
                 Pradesh, Mizoram, Nagaland, and high-burden       and diagnosis
                 districts of Assam) for early rollout          •   Integrate HPV vaccination of adolescent girls
             •   Use  self-collected  HPV  sampling  to  extend    as the upstream complement to screening, in
                 coverage into tribal, hill, and border populations   line with WHO’s 90-70-90 elimination targets,
                 where  facility-based  pelvic  examination  is  a   recognising that screening alone cannot close
                 major barrier to participation                    the gap in a region with this incidence profile
             •   Retain  Pap  cytology  as  the  principal  triage
                 test for HPV-positive women where cytology     Conclusion
                 infrastructure  already  exists,  while  building   Northeast India carries one of the highest cervical
                 capacity  for  partial  genotyping  or  alternative   cancer  burdens  in  the  country  and,  by  some
                 triage strategies over time                    indicators, among the highest in Asia. Yet screening
             •   Make  colposcopy  referral,  not  screening    and diagnostic capacity have not kept pace with
                 alone,  the  key  performance  indicator  of  the   this risk. Evidence clearly favours HPV DNA testing
                 programme,  track  and  report  the  proportion   over VIA and Pap cytology as a primary screening
                 of  screen-positive  women  who  actually      tool,  supported  by  self-sampling  for  hard-to-
                 complete colposcopic evaluation, not merely    reach hill, rural and tribal populations.
                 the proportion screened                        However,  screening  alone  is  not  enough.
             •   Decentralise  colposcopy  capacity  through    A  positive  result  must  lead  to  colposcopy,
                 structured  training  of  gynaecologists  and   histological  confirmation  and  timely  treatment.
                 surgical  oncology  trainees  at  district-level   For  the  Northeast,  meaningful  progress  will
                 facilities,  supported  by  tele-colposcopy  and   require  deliberate  investment  in  colposcopy
                 image-sharing with tertiary centres for quality   training,  equipment  and  decentralised  access
                 assurance                                      across district and community-level facilities. The
             •   Adopt  standardised  colposcopic  scoring      screening  pathway  will  only  save  lives  when  its
                 (e.g.,  Swede  score)  and  same-visit  biopsy/  weakest link, colposcopy, is strengthened.



































              34                                                                                                                                                                                                                      35
   29   30   31   32   33   34   35   36   37   38   39